Zuche Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.24 M
as on 17-11-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.90 Cr
as on 17-11-2024
- Satisfied Charges ₹ 6.00 Cr
as on 17-11-2024
- Revenue 48.51%
(FY 2023)
- Profit 38.10%
(FY 2023)
- Ebitda 67.84%
(FY 2023)
- Net Worth -11.68%
(FY 2023)
- Total Assets 32.57%
(FY 2023)
About Zuche Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.24 M.
The company currently has active open charges totaling ₹4.90 Cr. The company has closed loans amounting to ₹6.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Umesh Singh and Tarun Bharal serve as directors at the Company.
- CIN/LLPIN
U52100DL2010PTC206054
- Company No.
206054
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zuche Pharmaceuticals Private Limited offer?
Zuche Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Laxatives, Animal Medicines & Health Care, Veterinary Medicines, Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Veterinary Injections, Common Disease Medicines, Eye Drops, Ayurvedic,Herbal Products & Medicine.
Who are the key members and board of directors at Zuche Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Singh  | Director | 23-Jul-2021 | Current |
| Tarun Bharal | Director | 20-Jul-2010 | Current |
Financial Performance of Zuche Pharmaceuticals.
Zuche Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.51% increase. The company also saw a substantial improvement in profitability, with a 38.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zuche Pharmaceuticals?
In 2023, Zuche Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 21 Jul 2023 | ₹4.90 Cr | Open |
Axis Bank Limited Creation Date: 24 Dec 2021 | ₹8.50 M | Satisfied |
Axis Bank Limited Creation Date: 29 Oct 2021 | ₹2.45 Cr | Satisfied |
How Many Employees Work at Zuche Pharmaceuticals?
Zuche Pharmaceuticals has a workforce of 38 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zuche Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zuche Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
